Literature DB >> 3978563

The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer.

M B Hanson, J R van Nagell, D E Powell, E S Donaldson, H Gallion, M Merhige, E J Pavlik.   

Abstract

Surgical specimens from 111 patients with Stage I endometrial cancer were reviewed for the presence of lymph-vascular space invasion by tumor cells. Lymph-vascular space invasion was noted in 16 cases, and occurred most frequently in poorly differentiated tumors with deep myometrial penetration. Tumor recurrence developed in 44% of patients whose tumors demonstrated lymph-vascular space invasion as opposed to only 2% of patients without this finding (p less than 0.001). Of seven patients with lymph-vascular space invasion who experienced tumor recurrence, five developed extra-pelvic metastases. Discriminant function analysis of these data revealed a statistically significant correlation between lymph-vascular space invasion and tumor recurrence, independent of histologic differentiation of myometrial penetration. These findings suggest that lymph-vascular space invasion by tumor cells is an important prognostic variable in Stage I endometrial cancer which should be considered in treatment planning.

Entities:  

Mesh:

Year:  1985        PMID: 3978563     DOI: 10.1002/1097-0142(19850415)55:8<1753::aid-cncr2820550823>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer.

Authors:  Monica Mannelqvist; Ingunn M Stefansson; Geir Bredholt; Trond Hellem Bø; Anne M Oyan; Inge Jonassen; Karl-Henning Kalland; Helga B Salvesen; Lars A Akslen
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma.

Authors:  H Hareyama; N Sakuragi; S Makinoda; S Fujimoto
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

3.  Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer.

Authors:  Taejong Song; Jeong-Won Lee; Chel Hun Choi; Tae-Joong Kim; Duk-Soo Bae; Chang Ohk Sung; Sang Yong Song; Byoung-Gie Kim
Journal:  Int J Clin Oncol       Date:  2011-10-13       Impact factor: 3.402

4.  Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?

Authors:  S Jaishankar; P M Pifer; R Bhargava; A Keller; H B Musunuru; A K Patel; P Sukumvanich; M Boisen; J L Berger; S Taylor; M Courtney-Brooks; A Olawaiye; J Lesnock; R Edwards; J A Vargo; S Beriwal
Journal:  Clin Oncol (R Coll Radiol)       Date:  2022-03-06       Impact factor: 4.925

5.  Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.

Authors:  Soledad Jorge; June Y Hou; Ana I Tergas; William M Burke; Yongmei Huang; Jim C Hu; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2016-01-06       Impact factor: 5.482

6.  Metastatic involvement of the spleen by endometrial adenocarcioma; a rare asylum for a common malignancy: a case report.

Authors:  Adnan Arif; Zain Ul Abideen; Naeem Zia; Muhammad Atif Khan; Tariq Nawaz; Asif Zafar Malik
Journal:  BMC Res Notes       Date:  2013-11-19

7.  The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer.

Authors:  Wan Kyu Eo; Sanghoon Kwon; Suk Bong Koh; Min Jeong Kim; Yong Il Ji; Ji Young Lee; Dong Soo Suh; Ki Hyung Kim; Heung Yeol Kim
Journal:  J Cancer       Date:  2016-02-20       Impact factor: 4.207

8.  Prediction of lymphovascular space invasion in patients with endometrial cancer.

Authors:  Sang Il Kim; Joo Hee Yoon; Sung Jong Lee; Min Jong Song; Jin Hwi Kim; Hae Nam Lee; Gyul Jung; Ji Geun Yoo
Journal:  Int J Med Sci       Date:  2021-06-01       Impact factor: 3.738

9.  Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients.

Authors:  Alvaro Tejerizo-García; Jesús S Jiménez-López; José L Muñoz-González; Sara Bartolomé-Sotillos; Laura Marqueta-Marqués; Gregorio López-González; José F Pérez-Regadera Gómez
Journal:  Onco Targets Ther       Date:  2013-09-16       Impact factor: 4.147

10.  Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?

Authors:  Anna L Beavis; Ting-Tai Yen; Rebecca L Stone; Stephanie L Wethington; Caitlin Carr; Ji Son; Laura Chambers; Chad M Michener; Stephanie Ricci; Wesley C Burkett; Debra L Richardson; Allison-Stuart Staley; Susie Ahn; Paola A Gehrig; Diogo Torres; Sean C Dowdy; Mackenzie W Sullivan; Susan C Modesitt; Catherine Watson; Ashely Veade; Jessie Ehrisman; Laura Havrilesky; Angeles Alvarez Secord; Amy Loreen; Kaitlyn Griffin; Amanda Jackson; Akila N Viswanathan; Leah R Jager; Amanda N Fader
Journal:  Gynecol Oncol       Date:  2020-01-14       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.